Morgan Stanley »

Prelude Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 296k 4.74
2023-09-30 $755k 245k 3.09
2023-06-30 $879k 195k 4.50
2022-12-31 $543k 90k 6.04
2022-06-30 $1.9M 481k 4.02
2022-03-31 $3.5M 547k 6.35
2021-06-30 $0 132k 0.00
2020-12-31 $1.9M 27k 71.52
2020-09-30 $396k 13k 30.10